Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-006880

Chief Business Officer sold 6,944 shares at $69.91 ($485,424)

  • Chief Business Officer acquired 6,944 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Parrish Jay Chief Business Officer 2021-02-01 Option exercise +2,314 $1.49 $3,436 224,536 D
Parrish Jay Chief Business Officer 2021-02-01 Option exercise +4,630 $1.58 $7,292 229,166 D
Parrish Jay Chief Business Officer 2021-02-01 Sale −6,944 $69.91 $485,424 222,222 D
Derivatives
Parrish Jay Chief Business Officer 2021-02-01 Option exercise · Stock Option (Right to Buy) −2,314 13,889 D
Parrish Jay Chief Business Officer 2021-02-01 Option exercise · Stock Option (Right to Buy) −4,630 41,666 D
Open-market sales · 6,944 sh · avg $69.91 · $485,424
Loading xslF345X03/doc4.xml…